⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RAPT News
RAPT Therapeutics, Inc. Common Stock
Shareholder Alert: The Ademi Firm investigates whether RAPT Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders
prnewswire.com
RAPT
RAPT Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of RAPT Therapeutics, Inc. is Fair to Shareholders
businesswire.com
RAPT
Ray Therapeutics Appoints Scott Braunstein, M.D., as Chairman of the Board of Directors
businesswire.com
PCAR
ESPR
PRTA
LLY
CRBU
RAPT
RAPT Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
RAPT
Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
AMGN
PFE
LLY
AZN
BMY
NVS
SNY
GSK
UCB
ARQT
REGN
INCY
ABBV
BIIB
MRK
JNJ
VNDA
RAPT
CHAI
ONON
ION
ASMB
CRVS
APG
KSCP
KYMR
XBI
IBB
ADSK
CDNS
SNPS
RAPT Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
globenewswire.com
RAPT
RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences
globenewswire.com
RAPT
RAPT Therapeutics Initiates prestIgE Phase 2b Clinical Trial of Ozureprubart (RPT904) in Patients with Food Allergies
globenewswire.com
RAPT
RAPT Therapeutics Announces FDA Clearance of IND Application to Proceed to Phase 2b Trial of RPT904 in Food Allergy
globenewswire.com
RAPT